An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma

NCT00563056 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

227

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma Bronchiale

Interventions

DRUG: Flutiform
DRUG: Flixotide plus Foradil

Sponsor

Mundipharma Research Limited